1. The chart shows Zydus Lifesciences Limited on a weekly timeframe with recent bullish momentum, closing at 1036.85 INR.
2. A clear inverse head and shoulders pattern is marked, indicating a possible trend reversal from downtrend to uptrend.
3. The neckline resistance has been broken, confirming the pattern and suggesting potential upside movement.
4. Two targets are marked as per the pattern, with Target 1 at 1161.10 INR and Target 2 at 1262.05 INR.
5. Potential stop-loss levels are specified: a "tight SL" near 965.70 and a traditional pattern-based SL at 919.40.
6. Volume and RSI indicators show increased buying strength, with RSI above 60 signifying bullish momentum.
7. The breakout height (235.30) is projected upwards from the neckline for target calculation.
Educational disclaimer: This analysis is for educational purposes only and does not constitute financial advice; always do independent research before making investment decisions
2. A clear inverse head and shoulders pattern is marked, indicating a possible trend reversal from downtrend to uptrend.
3. The neckline resistance has been broken, confirming the pattern and suggesting potential upside movement.
4. Two targets are marked as per the pattern, with Target 1 at 1161.10 INR and Target 2 at 1262.05 INR.
5. Potential stop-loss levels are specified: a "tight SL" near 965.70 and a traditional pattern-based SL at 919.40.
6. Volume and RSI indicators show increased buying strength, with RSI above 60 signifying bullish momentum.
7. The breakout height (235.30) is projected upwards from the neckline for target calculation.
Educational disclaimer: This analysis is for educational purposes only and does not constitute financial advice; always do independent research before making investment decisions
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.